[1]
2022. Molecular Docking, Pre-ADME, And Pre-Tox Analysis Of Swainsonine And Castanospermine As Potential Glucokinase Activators. Journal of Pharmaceutical Negative Results. (Dec. 2022), 6456–6464. DOI:https://doi.org/10.47750/.